Crestline Management LP acquired a new stake in Hawkins, Inc. (NASDAQ:HWKN - Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 2,622 shares of the specialty chemicals company's stock, valued at approximately $322,000.
A number of other hedge funds and other institutional investors also recently made changes to their positions in HWKN. Wasatch Advisors LP acquired a new stake in shares of Hawkins in the fourth quarter valued at approximately $42,466,000. Vaughan Nelson Investment Management L.P. increased its holdings in Hawkins by 487.7% during the fourth quarter. Vaughan Nelson Investment Management L.P. now owns 254,837 shares of the specialty chemicals company's stock worth $31,260,000 after buying an additional 211,472 shares during the last quarter. Raymond James Financial Inc. acquired a new position in Hawkins during the fourth quarter worth $13,087,000. Cerity Partners LLC increased its holdings in Hawkins by 900.2% during the fourth quarter. Cerity Partners LLC now owns 82,576 shares of the specialty chemicals company's stock worth $10,166,000 after buying an additional 74,320 shares during the last quarter. Finally, JPMorgan Chase & Co. increased its holdings in Hawkins by 61.9% during the fourth quarter. JPMorgan Chase & Co. now owns 149,616 shares of the specialty chemicals company's stock worth $18,353,000 after buying an additional 57,179 shares during the last quarter. 69.71% of the stock is currently owned by institutional investors and hedge funds.
Hawkins Stock Performance
HWKN stock traded up $2.35 during midday trading on Friday, reaching $121.17. 37,232 shares of the company were exchanged, compared to its average volume of 130,963. The company has a debt-to-equity ratio of 0.23, a current ratio of 2.50 and a quick ratio of 1.53. The business has a 50-day moving average price of $114.02 and a two-hundred day moving average price of $117.03. Hawkins, Inc. has a one year low of $82.83 and a one year high of $139.55. The firm has a market capitalization of $2.54 billion, a price-to-earnings ratio of 30.91, a price-to-earnings-growth ratio of 3.80 and a beta of 0.87.
Hawkins (NASDAQ:HWKN - Get Free Report) last released its quarterly earnings data on Wednesday, May 14th. The specialty chemicals company reported $0.78 EPS for the quarter, topping analysts' consensus estimates of $0.74 by $0.04. Hawkins had a net margin of 8.60% and a return on equity of 18.95%. The firm had revenue of $245.32 million during the quarter, compared to analysts' expectations of $230.69 million. Equities research analysts forecast that Hawkins, Inc. will post 4 EPS for the current year.
Hawkins Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, June 13th. Shareholders of record on Friday, May 30th will be given a dividend of $0.18 per share. The ex-dividend date of this dividend is Friday, May 30th. This represents a $0.72 dividend on an annualized basis and a yield of 0.59%. Hawkins's dividend payout ratio (DPR) is 18.37%.
Analyst Upgrades and Downgrades
A number of equities analysts recently weighed in on the stock. BWS Financial restated a "buy" rating and set a $160.00 target price on shares of Hawkins in a report on Thursday. CJS Securities assumed coverage on shares of Hawkins in a report on Tuesday, April 1st. They set a "market outperform" rating and a $125.00 target price on the stock.
Check Out Our Latest Research Report on Hawkins
Hawkins Company Profile
(
Free Report)
Hawkins, Inc operates as a specialty chemical and ingredients company in the United States. It operates through three segments: Industrial, Water Treatment, and Health and Nutrition. The Industrial segment offers industrial chemicals, products, and services to agriculture, chemical processing, electronics, energy, food, pharmaceutical, and plating industries.
Featured Articles

Before you consider Hawkins, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hawkins wasn't on the list.
While Hawkins currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.